Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-22

FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application to market a generic mirtazapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)